Monday, September 25, 2017
 
 
Company News: Page (1) of 1 - 09/14/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Equicare Health ranks 217th on the 2017 PROFIT 500
 
(September 14, 2017)

VANCOUVER, Sept. 14, 2017 /PRNewswire/ - Equicare Health, the leading provider of oncology care coordination and patient navigation solutions, ranks 217th on the 29th annual PROFIT 500 as one of Canada's Fastest-Growing Companies.

"It is never easy to earn a spot on the PROFIT 500, but this year's applicant pool was the most competitive yet," says Deborah Aarts, PROFIT 500 Program Manager. "This year's winners demonstrate the resilience, innovation and sheer management smarts it takes to build a thriving business today. Canada?and the world?needs more entrepreneurial success stories like these."

PROFIT 500 is an annual listing that ranks Canadian businesses by their five-year revenue growth. This year, PROFIT 500 companies will be published in the October issue of Maclean's magazine and CanadianBusiness.com


"Equicare is honoured to be part of this year's PROFIT 500, being recognized alongside many innovative companies nationwide," says Len Grenier, CEO at Equicare Health. "Our continued success reflects the hard work and commitment of our team. We will continue to build on our successes and deliver leading oncology care coordination solutions to cancer patients and oncology care providers."

PROFIT 500 follows Equicare's recent recognition as one of Business in Vancouver's (BIV) Fastest Growing Companies earlier this month.

About Equicare Health
Equicare Health is the industry's leading provider of comprehensive care coordination solutions. Equicare's flagship solution EQUICARE CS (ECS) is a Multi-facility web-based software tool that facilitates patient engagement including patient reported outcomes, patient navigation, survivorship care and a number of other clinical tools, i.e. MDT, Clinical trials, a suite of educational material, etc.. In additional to the clinical toolset, Equicare also offers an administrative suite of worklists and reports for managing adherence to accreditation standards including Meaningful Use, Commission on Cancer (CoC), NAPBC, QOPI, OCM, etc... ECS enables cancer centers to influence clinical outcomes for patients, optimize revenue streams, and increase operational efficiency. www.equicarehealth.com

About the PROFIT 500
For 29 years, the PROFIT 500 has been Canada's most respectable and influential ranking of entrepreneurial achievement. Developed by PROFIT and now published in Maclean's magazine and at CanadianBusiness.com, the PROFIT 500 ranks Canadian companies on five-year revenue growth. For more information on the ranking visit PROFIT500.com or CanadianBusiness.com.

About Canadian Business
Founded in 1928, Canadian Business is the longest-serving and most-trusted business publication in the country. It is the country's premier media brand for executives and senior business leaders. It fuels the success of Canada's business elite with a focus on the things that matter most: leadership, innovation, business strategy and management tactics. Learn more at CanadianBusiness.com.

SOURCE Equicare Health Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Science, Medical, Cancer, Business, Other,
Related Sites: AEC Newsroom ,   DMN Newswire ,   IBN - SoftwareDev ,   HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
Seniors

Drugs
  • The High-Tech Future of Home Healthcare
  • A Medical Implants Manufacturer Used Salesforce Effectiveness Solution to Improve Salesforce Performance Provided by Quantzig
  • Point of Care Technology Market :Company information, geographical data and Market Analysis
  • Dental Market Trends, Size, Growth, Leading Players, Opportunities and 2021 Global Analysis Forecasts Discussed in New Research Report
  • Human Genetics Market Dynamics, Comprehensive Analysis, Business Growth, Prospects and Opportunities 2016-2024

    Cancer
  • Targovax granted US Patent for mutant-RAS neoantigen platform lead products
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Hammertoe Market US $ 450 Million Acquire A Massive Growth By 2023
  • Crux Quality Solutions To Exhibit And Demo Workflow Automation Tool, FlowBoard At ASTRO 2017 Annual Meeting
  • Elekta and Brainlab Collaborate to Streamline Treatment Workflows for Stereotactic Radiation Therapy
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines